MXPA04001659A - El uso de antroquinonas en el tratamiento de enfermedad renal. - Google Patents

El uso de antroquinonas en el tratamiento de enfermedad renal.

Info

Publication number
MXPA04001659A
MXPA04001659A MXPA04001659A MXPA04001659A MXPA04001659A MX PA04001659 A MXPA04001659 A MX PA04001659A MX PA04001659 A MXPA04001659 A MX PA04001659A MX PA04001659 A MXPA04001659 A MX PA04001659A MX PA04001659 A MXPA04001659 A MX PA04001659A
Authority
MX
Mexico
Prior art keywords
treatment
anthroquinones
kidney disease
conditions
renal
Prior art date
Application number
MXPA04001659A
Other languages
English (en)
Inventor
Mark Bannister Robin
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0120788A external-priority patent/GB0120788D0/en
Priority claimed from GB0120783A external-priority patent/GB0120783D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of MXPA04001659A publication Critical patent/MXPA04001659A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/30—Hydrogen technology
    • Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una antroquinona tal como diacereina es util para el tratamiento de condiciones renales y condiciones (tal como SLE) que conducen al dano renal.
MXPA04001659A 2001-08-25 2002-08-27 El uso de antroquinonas en el tratamiento de enfermedad renal. MXPA04001659A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0120788A GB0120788D0 (en) 2001-08-25 2001-08-25 The treatment of kidney disease
GB0120783A GB0120783D0 (en) 2001-08-25 2001-08-25 The treatment of lupus nephritis
PCT/GB2002/003921 WO2003017997A1 (en) 2001-08-25 2002-08-27 The use of anthroquinones in the treatment of kidney disease

Publications (1)

Publication Number Publication Date
MXPA04001659A true MXPA04001659A (es) 2004-05-31

Family

ID=26246480

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001659A MXPA04001659A (es) 2001-08-25 2002-08-27 El uso de antroquinonas en el tratamiento de enfermedad renal.

Country Status (13)

Country Link
US (1) US20040248864A1 (es)
EP (1) EP1418901A1 (es)
JP (1) JP2005504054A (es)
CN (1) CN1547468A (es)
BR (1) BR0211948A (es)
CA (1) CA2458129A1 (es)
HU (1) HUP0401640A2 (es)
IL (1) IL160310A0 (es)
MX (1) MXPA04001659A (es)
NO (1) NO20040815L (es)
NZ (1) NZ530956A (es)
PL (1) PL369123A1 (es)
WO (1) WO2003017997A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1748675A (zh) 2005-07-11 2006-03-22 丛晓东 大黄酸类化合物的复合物及制备方法与治疗糖尿病的应用
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
CN101537002B (zh) * 2009-04-24 2012-02-29 安士制药（中山）有限公司 具有优良溶出性能的双醋瑞因组合物及其制备和用途
CN104042594A (zh) * 2013-03-15 2014-09-17 复旦大学 蒽醌类化合物在制备抗补体药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1086289C (zh) * 1997-09-30 2002-06-19 中国人民解放军肾脏病研究所 大黄酸或大黄酸盐在制备治疗糖尿病肾病药中的用途
US6197818B1 (en) * 1998-09-01 2001-03-06 Nanjing General Hospital Of Nanjing Command, Pla Drug for treating diabetic nephrosis
US7087608B2 (en) * 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy

Also Published As

Publication number Publication date
JP2005504054A (ja) 2005-02-10
NZ530956A (en) 2005-08-26
NO20040815L (no) 2004-02-24
US20040248864A1 (en) 2004-12-09
PL369123A1 (en) 2005-04-18
HUP0401640A2 (hu) 2004-12-28
BR0211948A (pt) 2004-09-14
EP1418901A1 (en) 2004-05-19
CN1547468A (zh) 2004-11-17
WO2003017997A1 (en) 2003-03-06
IL160310A0 (en) 2004-07-25
CA2458129A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
IN2004CH02386A (es)
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
HK1091112A1 (en) Compounds and methods for increasing neurogenesis
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
BR0212924A (pt) Inibidores de glicogênio sintase quinase-3 (gsk-3) para o tratamento de glaucoma
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
SG155947A1 (en) Compositions and methods for the diagnosis and treatment of tumor
BR0312785A (pt) Tratamento de desordens relacionadas a tnf(alfa)
AP2002002426A0 (en) Ppar agonists
CA2400377A1 (en) Method for treating ocular pain
DE50208151D1 (de) Schwingdrossel
SI1648484T1 (sl) Farmacevtske oblike za zdravljenje artritiäśnih stanj
SI1581235T1 (sl) Uporaba spongozin (2-metoksiadenozeina) za zdravljenje bolečine, zlasti hiperalgezije
IL145557A (en) Immunoabsorber for use in sepsis therapy
AU2002354951A1 (en) Use of copper chelators to inhibit the inactivation of protein c
SI1546182T1 (sl) Sestavki in postopki za diagnozo in zdravljenje tumorja
BR0317857A (pt) Tratamento de anorexia nervosa (an) e bulimia
GB0003025D0 (en) Novel compounds
PL367287A1 (en) Use of proteasome inhibitors to treat dry eye disorders
MXPA03010323A (es) Compuestos y metodos para inhibir el mal olor axilar.
HK1048308A1 (en) Novel compounds.
AU2001246600A1 (en) Use of comt inhibitors as analgesics
SE0300795D0 (sv) Composition comprising iscom particles and live micro-organisms
MXPA04001659A (es) El uso de antroquinonas en el tratamiento de enfermedad renal.
GB0016052D0 (en) Ruthenium (II) compounds

Legal Events

Date Code Title Description
FA Abandonment or withdrawal